Low Dose Plerixafor Plus G-CSF in Mobilizing Stem Cells for Autologous Peripheral Blood Transplantation

NCT03244930 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Non-Hodgkin
Lymphoma, Hodgkin
Myeloma
Stem Cell Transplant Complications

Interventions

DRUG: Plerixafor 0.12 mg/kg

Sponsor

Hospital Universitario Dr. Jose E. Gonzalez